Boston Research & Management’s Stryker SYK Stock Holding History

Boston Research & Management’s Portfolio SYK Stock Details SYK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.43M	Hold	4,354	–	–	0.34%	65
2025 Q4	$1.53M	Hold	4,354	–	–	0.35%	64
2025 Q3	$1.61M	Hold	4,354	–	–	0.35%	65
2025 Q2	$1.72M	Hold	4,354	–	–	0.41%	60
2025 Q1	$1.62M	Hold	4,354	–	–	0.4%	60
2024 Q4	$1.57M	Hold	4,354	–	–	0.38%	62
2024 Q3	$1.57M	Hold	4,354	–	–	0.37%	64
2024 Q2	$1.48M	Hold	4,354	–	–	0.37%	64
2024 Q1	$1.56M	Hold	4,354	–	–	0.39%	64
2023 Q4	$1.3M	Hold	4,354	–	–	0.35%	66
2023 Q3	$1.19M	Hold	4,354	–	–	0.35%	67
2023 Q2	$1.33M	Hold	4,354	–	–	0.38%	67
2023 Q1	$1.24M	Hold	4,354	–	–	0.37%	65
2022 Q4	$1.06M	Hold	4,354	–	–	0.33%	68
2022 Q3	$881K	Hold	4,354	–	–	0.3%	70
2022 Q2	$866K	Hold	4,354	–	–	0.28%	71
2022 Q1	$1.16M	Hold	4,354	–	–	0.34%	69
2021 Q4	$1.16M	Hold	4,354	–	–	0.32%	68
2021 Q3	$1.15M	Hold	4,354	–	–	0.34%	66
2021 Q2	$1.13M	Hold	4,354	–	–	0.34%	64
2021 Q1	$1.06M	Hold	4,354	–	–	0.34%	64
2020 Q4	$1.07M	Sell	4,354 -6	-0.1%	-$1.36K	0.37%	64
2020 Q3	$908K	Hold	4,360	–	–	0.36%	64
2020 Q2	$785K	Buy	4,360 +6	+0.1%	+$1.11K	0.33%	63
2020 Q1	$724K	Sell	4,354 -180	-4%	-$35.2K	0.36%	60
2019 Q4	$951K	Hold	4,534	–	–	0.36%	61
2019 Q3	$980K	Hold	4,534	–	–	0.39%	61
2019 Q2	$932K	Hold	4,534	–	–	0.38%	62
2019 Q1	$895K	Hold	4,534	–	–	0.37%	62
2018 Q4	$710K	Hold	4,534	–	–	0.34%	63
2018 Q3	$805K	Hold	4,534	–	–	0.37%	64
2018 Q2	$765K	Hold	4,534	–	–	0.38%	64
2018 Q1	$729K	Hold	4,534	–	–	0.37%	62
2017 Q4	$702K	Sell	4,534 -100	-2%	-$15.3K	0.35%	64
2017 Q3	$658K	Hold	4,634	–	–	0.34%	65
2017 Q2	$643K	Hold	4,634	–	–	0.35%	66
2017 Q1	$610K	Hold	4,634	–	–	0.33%	68
2016 Q4	$555K	Hold	4,634	–	–	0.32%	70
2016 Q3	$539K	Hold	4,634	–	–	0.31%	69
2016 Q2	$555K	Hold	4,634	–	–	0.34%	66
2016 Q1	$497K	Hold	4,634	–	–	0.31%	70
2015 Q4	$430K	Hold	4,634	–	–	0.27%	77
2015 Q3	$436K	Hold	4,634	–	–	0.29%	76
2015 Q2	$442K	Sell	4,634 -90	-2%	-$8.53K	0.28%	74
2015 Q1	$435K	Hold	4,724	–	–	0.28%	75
2014 Q4	$445K	Hold	4,724	–	–	0.28%	77
2014 Q3	$381K	Hold	4,724	–	–	0.26%	76
2014 Q2	$398K	Hold	4,724	–	–	0.28%	74
2014 Q1	$384K	Hold	4,724	–	–	0.28%	74
2013 Q4	$354K	Hold	4,724	–	–	0.27%	71
2013 Q3	$319K	Hold	4,724	–	–	0.27%	73
2013 Q2	$305K	Buy	+4,724	New	+$314K	0.27%	71

Other funds holding SYK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Greenleaf Trust Kalamazoo, Michigan $10.4B AUM 0.97% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Boston Research & Management's SYK Position: Q1 2026 in Review

Boston Research & Management held its Stryker (SYK) position steady in Q1 2026 at 4,354 shares worth $1.43M. The position accounts for 0.34% of the portfolio, ranked #65.

Boston Research & Management first reported a position in SYK in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.72M in Q2 2025. 2,295 funds tracked by Wall St. Rank hold SYK as of Q1 2026.

Boston Research & Management held 4,354 shares of Stryker worth $1.43M as of Q1 2026.
Boston Research & Management left its Stryker share count unchanged in Q1 2026.
Stryker made up 0.34% of Boston Research & Management's portfolio in Q1 2026, its #65 holding.
Boston Research & Management first reported a position in Stryker in Q2 2013 and has held it in 52 quarters since.
Boston Research & Management's Stryker position peaked at $1.72M in Q2 2025.
2,295 funds tracked by Wall St. Rank held Stryker as of Q1 2026.

Based on Boston Research & Management's 13F filing for Q1 2026, filed 10 Apr 2026.